These 10 medtech companies care a lot about research

October 17, 2018 By Danielle Kirsh

10. Cochlear

R&D spending: $167,700,000

Percentage of revenues: 12.4%

2018 overall revenue ranking: 53

[Image from Cochlear]

One of the most significant devices to come out of Cochlear‘s (New South Wales, Australia) R&D department in recent years is the Nucleus 7 sound processor. The Australia-based company touts the Nucleus 7 as the world’s first made-for-smartphone cochlear implant sound processor — compatible with both iOS and Android devices.

A small, behind-the-ear implant sound processor, the Nucleus 7 is available to people who have a Nucleus 24 series implant.

Next >>

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.